Metis Global Partners’s Eli Lilly LLY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $42.4M | Buy |
54,401
+1,053
| +2% | +$821K | 1.09% | 14 |
|
|
2025
Q1 | $44.1M | Buy |
53,348
+5,225
| +11% | +$4.32M | 1.24% | 13 |
|
|
2024
Q4 | $37.2M | Buy |
48,123
+913
| +2% | +$705K | 1.12% | 13 |
|
|
2024
Q3 | $41.8M | Buy |
47,210
+1,108
| +2% | +$982K | 1.3% | 12 |
|
|
2024
Q2 | $41.7M | Sell |
46,102
-222
| -0.5% | -$201K | 1.43% | 12 |
|
|
2024
Q1 | $36M | Buy |
46,324
+107
| +0.2% | +$83.2K | 1.31% | 12 |
|
|
2023
Q4 | $26.9M | Buy |
46,217
+5,332
| +13% | +$3.11M | 1.07% | 16 |
|
|
2023
Q3 | $22M | Buy |
40,885
+5,544
| +16% | +$2.98M | 1.06% | 15 |
|
|
2023
Q2 | $16.6M | Buy |
35,341
+1,606
| +5% | +$753K | 0.89% | 16 |
|
|
2023
Q1 | $11.6M | Buy |
33,735
+8,383
| +33% | +$2.88M | 0.74% | 20 |
|
|
2022
Q4 | $9.27M | Buy |
25,352
+10,076
| +66% | +$3.69M | 0.83% | 19 |
|
|
2022
Q3 | $4.94M | Buy |
15,276
+1,636
| +12% | +$529K | 0.8% | 17 |
|
|
2022
Q2 | $4.42M | Buy |
13,640
+815
| +6% | +$264K | 0.71% | 23 |
|
|
2022
Q1 | $3.67M | Buy |
12,825
+5,299
| +70% | +$1.52M | 0.44% | 31 |
|
|
2021
Q4 | $2.08M | Buy |
+7,526
| New | +$2.08M | 0.58% | 32 |
|